Strengthening Security for Gene Synthesis: Recommendations for Governance

Area of Science:

• Biosecurity
• Molecular Biology
• Public Health Policy

Background:

• Gene synthesis technology enables the creation of pathogens, raising biosecurity concerns.
• Existing regulations, like the 2010 US Department of Health and Human Services (HHS) Guidance, aim to mitigate misuse risks.
• The International Gene Synthesis Consortium (IGSC) was established to share screening methods among major providers.

Purpose of the Study:

• To evaluate the effectiveness of current biosecurity measures in gene synthesis.
• To identify how technological and market changes impact biosecurity protections.
• To recommend updates to existing guidance and propose new international governance strategies.

Main Methods:

• Analysis of changes in gene synthesis technologies and market conditions since 2010.
• Review of the efficacy of existing sequence and customer screening protocols.
• Assessment of current international biosecurity governance frameworks.

Main Results:

• Technological advancements and market shifts have potentially reduced the effectiveness of 2010 biosecurity guidance.
• Current screening methods may not fully address emerging risks associated with gene synthesis.
• There is a need for updated biosecurity strategies and enhanced international cooperation.

Conclusions:

• The 2010 HHS Guidance requires updates to remain effective against evolving gene synthesis risks.
• Governments should implement new measures and foster international collaboration to strengthen biosecurity.
• Proactive engagement with nations involved in gene synthesis research is crucial for global safety.